Valentis Posts Sharp Revenue Decline, But R&D Cuts Help Narrow Q3 Loss | GenomeWeb

NEW YORK, Nov. 15 - Valentis today said a significant decrease in R&D and other expenses in the third quarter offset dismal revenue and helped narrow net loss.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.